Literature DB >> 32033911

The Undiagnosed Diseases Network International: Five years and more!

D Taruscio1, G Baynam2, H Cederroth3, S C Groft4, E W Klee5, K Kosaki6, P Lasko7, B Melegh8, O Riess9, M Salvatore10, W A Gahl11.   

Abstract

Undiagnosed rare diseases (URDs) account for a significant portion of the overall rare disease burden, depending upon the country. Hence, URDs represent an unmet medical need. A specific challenge posed by the ensemble of the URD patient cohort is the heterogeneity of its composition; the group, indeed, includes very rare, still unidentified conditions as well as clinical variants of recognized rare diseases. Exact disease recognition requires new approaches that cut across national and institutional boundaries, may need the implementation of methods new to diagnostics, and embrace clinical care and research. To address these issues, the Undiagnosed Diseases Network International (UDNI) was established in 2014, with the major aims of providing diagnoses to patients, implementing additional diagnostic tools, and fostering research on novel diseases, their mechanisms, and their pathways. The UDNI involves centres with internationally recognized expertise, and its scientific resources and know-how aim to fill the knowledge gaps that impede diagnosis, in particularly for ultra-rare diseases. Consequently, the UDNI fosters the translation of research into medical practice, aided by active patient involvement. The goals of the UDNI are to work collaboratively and at an international scale to: 1) provide diagnoses for individuals who have conditions that have eluded diagnosis by clinical experts; 2) gain insights into the etiology and pathogenesis of novel diseases; 3) contribute to standards of diagnosing unsolved patients; and 4) share the results of UDNI research in a timely manner and as broadly as possible.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Diagnosis; Global health; Omics; Ontology; Rare diseases; Undiagnosed

Mesh:

Year:  2020        PMID: 32033911     DOI: 10.1016/j.ymgme.2020.01.004

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

1.  ModelMatcher: A scientist-centric online platform to facilitate collaborations between stakeholders of rare and undiagnosed disease research.

Authors:  J Michael Harnish; Lucian Li; Sanja Rogic; Guillaume Poirier-Morency; Seon-Young Kim; Kym M Boycott; Michael F Wangler; Hugo J Bellen; Philip Hieter; Paul Pavlidis; Zhandong Liu; Shinya Yamamoto
Journal:  Hum Mutat       Date:  2022-03-24       Impact factor: 4.700

Review 2.  Multifactorial Rare Diseases: Can Uncertainty Analysis Bring Added Value to the Search for Risk Factors and Etiopathogenesis?

Authors:  Domenica Taruscio; Alberto Mantovani
Journal:  Medicina (Kaunas)       Date:  2021-01-28       Impact factor: 2.430

3.  FAIR Genomes metadata schema promoting Next Generation Sequencing data reuse in Dutch healthcare and research.

Authors:  Jeroen A M Beliën; Mariëlle E van Gijn; Morris A Swertz; K Joeri van der Velde; Gurnoor Singh; Rajaram Kaliyaperumal; XiaoFeng Liao; Sander de Ridder; Susanne Rebers; Hindrik H D Kerstens; Fernanda de Andrade; Jeroen van Reeuwijk; Fini E De Gruyter; Saskia Hiltemann; Maarten Ligtvoet; Marjan M Weiss; Hanneke W M van Deutekom; Anne M L Jansen; Andrew P Stubbs; Lisenka E L M Vissers; Jeroen F J Laros; Esther van Enckevort; Daphne Stemkens; Peter A C 't Hoen
Journal:  Sci Data       Date:  2022-04-13       Impact factor: 8.501

4.  Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network.

Authors:  Marco Salvatore; Agata Polizzi; Maria Chiara De Stefano; Giovanna Floridia; Simone Baldovino; Dario Roccatello; Savino Sciascia; Elisa Menegatti; Giuseppe Remuzzi; Erica Daina; Paraskevas Iatropoulos; Bruno Bembi; Rosalia Maria Da Riol; Alessandra Ferlini; Marcella Neri; Giuseppe Novelli; Federica Sangiuolo; Francesco Brancati; Domenica Taruscio
Journal:  Ital J Pediatr       Date:  2020-09-14       Impact factor: 2.638

Review 5.  Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease.

Authors:  Yuichi Yamamoto; Norihiro Kanayama; Yusuke Nakayama; Nobuko Matsushima
Journal:  J Pers Med       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.